vs
Side-by-side financial comparison of Chatham Lodging Trust (CLDT) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $67.7M, roughly 1.0× Chatham Lodging Trust). Chatham Lodging Trust runs the higher net margin — 6.8% vs -49.0%, a 55.8% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -9.8%).
Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
CLDT vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $67.7M | $70.6M |
| Net Profit | $4.6M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 15.9% | -56.7% |
| Net Margin | 6.8% | -49.0% |
| Revenue YoY | -9.8% | 81958.1% |
| Net Profit YoY | 369.9% | 54.9% |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $67.7M | — | ||
| Q3 25 | $78.4M | $70.6M | ||
| Q2 25 | $80.3M | — | ||
| Q1 25 | $68.6M | — | ||
| Q4 24 | $75.1M | — | ||
| Q3 24 | $87.2M | — | ||
| Q2 24 | $86.5M | — | ||
| Q1 24 | $68.4M | — |
| Q4 25 | $4.6M | — | ||
| Q3 25 | $3.5M | $-34.6M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $6.8M | — | ||
| Q1 24 | $-5.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 40.7% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 38.9% | — |
| Q4 25 | 15.9% | — | ||
| Q3 25 | 12.7% | -56.7% | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | 16.3% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 4.5% | -49.0% | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | -7.6% | — |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $-0.08 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $-0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.4M | $490.9M |
| Total DebtLower is stronger | $338.9M | — |
| Stockholders' EquityBook value | $740.8M | $503.0M |
| Total Assets | $1.2B | $577.1M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.4M | — | ||
| Q3 25 | $13.2M | $490.9M | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $18.6M | — | ||
| Q4 24 | $20.2M | — | ||
| Q3 24 | $19.3M | — | ||
| Q2 24 | $10.6M | — | ||
| Q1 24 | $72.3M | — |
| Q4 25 | $338.9M | — | ||
| Q3 25 | $338.8M | — | ||
| Q2 25 | $351.2M | — | ||
| Q1 25 | $381.1M | — | ||
| Q4 24 | $406.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $740.8M | — | ||
| Q3 25 | $749.4M | $503.0M | ||
| Q2 25 | $754.1M | — | ||
| Q1 25 | $754.7M | — | ||
| Q4 24 | $758.2M | — | ||
| Q3 24 | $765.3M | — | ||
| Q2 24 | $766.5M | — | ||
| Q1 24 | $765.0M | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $577.1M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.1M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 13.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.1M | — | ||
| Q3 25 | $25.6M | $-84.6M | ||
| Q2 25 | $22.1M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $73.8M | — | ||
| Q3 24 | $28.8M | — | ||
| Q2 24 | $25.2M | — | ||
| Q1 24 | $6.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 13.90× | — | ||
| Q3 25 | 7.24× | — | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 2.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.78× | — | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLDT
| Occupancy | $61.5M | 91% |
| Hotel Other | $4.2M | 6% |
| Food And Beverage | $1.8M | 3% |
| Hotel | $1.1M | 2% |
VRDN
Segment breakdown not available.
